Antitrust Law

Asbestos Law

Civil Rights Law

Communications Law

Contract Law

Dispute Resolution

Divorce Law

Education Law

Family Law

Health Law

Immigration Law


Internet Law

Intellectual Property

Landlord Tenant Law

Law Schools

Lawsuit Funding

Lemon Law

Medical Malpractice

Other Law Fields

Personal Injury

Prepaid Legal Services

Structured Settlement

Tax Law

Workers Comp


Free Legal Advice

Online Legal Forms

Legal Answers

Legal Definitions

Advertise on LDB




Navigation:  Home > Class Action Law> PPA


On May 11, 2000, the FDA received results of a study conducted by scientists at Yale University School of Medicine that showed an increased risk of hemorrhagic stroke in people who were taking phenylpropanolamine, or PPA. The FDA issued a public health advisory. The drug is an ingredient used in many over-the-counter and prescription cough and cold medications as a decongestant as well as weight loss products.

Several lawsuits have been filed charging that several manufacturers of products containing PPA knew that the ingredient could potentially cause hemorrhagic strokes but failed to warn consumers of such risks. Although the risk of hemorrhagic stroke is very low, the FDA recommends that consumers not use any products that contain PPA. The FDA is possibly in the process of formulating a policy to potentially ban PPA.

Some name brand products that contain PPA include Acutrim 16-hour tablets, Alka Seltzer Plus Cold, Comtrex Deep Chest,  Dexatrim Caffeine Free Caplet, Dimetapp Cold and Cough, Robitussin CF, Tavist D, and Triaminic Cough. If you have experienced a stroke and have taken a drug containing PPA you may be able to sue the manufacturers of the drug.

Sponsored Ads

Find a Lawyer

Sponsored Links

Your Ad Here